If antibodies were our only defense, surely we would be seeing vast numbers of reinfections?
By Ross Clark
No one is telling Americans to ‘look at the EU’ anymore
By Ross Clark
A Stanford professor has produced perhaps the most comprehensive attempt to estimate the infection fatality rate
By Ross Clark
A team at the University of Nevada has been studying him
By Ross Clark
It was therapeutic drugs that in the end made HIV less deadly
By Ross Clark
Several studies bring into question a central assumption of the global response to COVID-19
By Ross Clark
New cases are now declining in Germany, and Sweden, and remaining flat in Italy, Ireland and Belgium
By Ross Clark
Are we fearing a ‘second wave’ which our immune systems already have well in hand?
By Ross Clark
Perhaps it is time for governments to start looking at real world evidence, rather than just models
By Ross Clark
Introducing novel drugs into everyday use has the potential to bring a huge amount of good — but also the potential to cause a great deal of harm
By Ross Clark
Gender-based study is permissible when it presents women in a positive light, and absolutely forbidden when it does not
By Ross Clark
Over the first half of the year the Swedish economy shrank by a little less than did Denmark’s
By Ross Clark
The truth is neither as good as the President makes out, nor as bad as his critics claim
By Ross Clark
At the moment it looks pretty benign
By Ross Clark
